Cassidy To FDA: It’s Your Job, Not FTC’s, To Clarify Orange Book Listings For Combo Products

The Senate health committee’s top Republican says the Federal Trade Commission (FTC) has exceeded its authority by trying to eliminate "junk" patent listings in FDA's Orange Book, and he demands FDA clarify patent listings for drug-device combination products rather than leaving the responsibility to FTC. “Letting FTC enforce terms of the FDCA is an extraordinary abdication of authority by FDA,” Sen. Bill Cassidy (R-LA) says in a letter sent to FDA Commissioner Robert Califf Monday (Sept. 30). “FTC’s actions have...